Comments
Loading...
Teva Pharmaceutical Indus (NYSE:TEVA) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Teva Pharmaceutical Indus (TEVA)?
The most recent guidance for Teva Pharmaceutical Indus (TEVA) was reported on November 6, 2024 for the full year 2024. The company provided earnings per share guidance in the range of $2.40 to $2.50, compared to the estimated EPS of $2.45. Additionally, Teva Pharmaceutical Indus forecasted revenue between $16.10B and $16.50B for the quarter.
Browse guidance and forecast on all stocks.